Raychaudhuri P, Bagchi S, Devoto S H, Kraus V B, Moran E, Nevins J R
Howard Hughes Medical Institute, Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27710.
Genes Dev. 1991 Jul;5(7):1200-11. doi: 10.1101/gad.5.7.1200.
Recent experiments have shown that the cellular E2F transcription factor is found in complexes with cellular proteins and that one such complex contains the cyclin-A protein. Isolation of a cellular activity, which we term E2F-BF, can reconstitute the E2F-cyclin-A complex and has permitted a more detailed analysis of the mechanism of E1A dissociation. Through the analysis of a series of E1A mutants, we find that sequences in conserved region 1 (CR1) and conserved region 2 (CR2) are important for dissociation of the E2F complex, whereas amino-terminal sequences are not required. In contrast to the requirements for dissociation, only the CR1 sequences are required to block formation of the complex if E1A is added when the components are combined. We have also identified an activity, termed E2F-I, that inhibits E2F binding to DNA, again apparently through the formation of a complex with E2F. This inhibitory activity is also blocked by E1A, dependent on the same elements of the E1A protein that disrupt the interaction with E2F-BF. Because the E1A sequences that are important for releasing E2F from these interactions are also sequences necessary for oncogenesis, we suggest that this activity may be a critical component of the transforming activity of E1A.
最近的实验表明,细胞E2F转录因子存在于与细胞蛋白形成的复合物中,并且其中一种复合物含有细胞周期蛋白A。一种我们称为E2F-BF的细胞活性的分离能够重组E2F-细胞周期蛋白A复合物,并使得对E1A解离机制的更详细分析成为可能。通过对一系列E1A突变体的分析,我们发现保守区域1(CR1)和保守区域2(CR2)中的序列对于E2F复合物的解离很重要,而氨基末端序列则不需要。与解离的要求相反,如果在组分混合时加入E1A,仅CR1序列对于阻止复合物的形成是必需的。我们还鉴定出一种称为E2F-I的活性,它抑制E2F与DNA的结合,显然也是通过与E2F形成复合物来实现的。这种抑制活性也被E1A阻断,这依赖于E1A蛋白中破坏与E2F-BF相互作用的相同元件。因为对于从这些相互作用中释放E2F很重要的E1A序列也是肿瘤发生所必需的序列,所以我们认为这种活性可能是E1A转化活性的关键组成部分。